MBX Earnings & Financial Statements
MBX Biosciences, Inc. Common Stock
$50.71
+$1.89(+3.87%)
49
Overall
60
Value
54
Tech
34
Quality
Market Cap
$2.35B
Volume
601.76K
52W Range
$12.94 - $72.64
Target Price
$84.73
MBX earnings and financial statements: MBX Biosciences, Inc. Common Stock's income statement, balance sheet and cash flow statement, annual and quarterly.
MBX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating income | -$98.06M | -$68.19M | -$35.31M | -$26.06M |
| EBITDA | -$86.72M | -$61.68M | -$32.41M | -$25.70M |
| Net income | -$86.97M | -$61.92M | -$32.56M | -$26.14M |
| EPS (diluted) | $-2.38 | $-5.82 | $-31.96 | $-39.18 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $385.14M | $268.54M | $84.18M | $45.09M |
| Total liabilities | $15.92M | $11.09M | $4.29M | $3.82M |
| Shareholders’ equity | $369.22M | $257.44M | $79.89M | $41.27M |
| Cash and equivalents | $75.29M | $49.35M | $30.52M | $24.21M |
| Long-term debt | $424.0K | - | $171.0K | $324.0K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -$79.95M | -$54.68M | -$31.98M | -$23.12M |
| Capital expenditure | -$1.93M | -$874.0K | - | - |
| Free cash flow | -$81.88M | -$55.55M | -$32.11M | -$23.56M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MBX | $50.71 | +3.9% | 601.76K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get MBX Biosciences, Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW